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Objective: This study represents the development of a treatment and seeding
procedure to improve endothelial cellular adhesion on glutaraldehyde-fixed valves.
Methods: Porcine aortic valves were fixed with 0.2% glutaraldehyde. Wall pieces of
these valves had either no additional treatment (n  4), incubation in M199 Earle
(1), with sodium carbonate at 2.2 g/L without L-glutamine for 24 hours (n  4),
or additional pretreatment with 5%, 10%, or 15% citric acid (three groups, n  4
each). Thereafter the pieces were washed and buffered to a physiologic pH. This
was followed by seeding of human endothelial cells (5  106 cells). On the basis of
the results of these pilot tests, complete glutaraldehyde-fixed aortic roots treated
with 10% citric acid were subjected to cell seeding. The valves were seeded with
endothelial cells (4.3  106 cells) either alone (n  4) or in combination with
preseeding of autologous fibroblasts (2.4  107 cells, n  4). After each seeding
procedure specimens of the free wall of the grafts were taken. In addition, one leaflet
was taken for histologic examination after endothelial cell seeding, after 7 days, and
after 21 days. Finally, two commercially available stentless aortic valve prostheses
(Freestyle; Medtronic, Inc, Minneapolis, Minn) were treated with 10% citric acid
and seeded with human fibroblasts and endothelial cells. Specimen were taken
according to the glutaraldehyde-fixed aortic roots. Specimen of all experiments were
examined with scanning electron microscopy. Frozen sections were stained immu-
nohistochemically for collagen IV, factor VIII, and CD31.
Results: On untreated glutaraldehyde-fixed aortic wall pieces, only poor adhesion
(24%) was seen. No viable cells were found after 1 week. Cellular adhesion was best
on aortic wall pieces pretreated with 10% citric acid. After 7 days, the cells formed
a confluent layer. Endothelial cell seeding on citric acid-treated complete aortic
valves showed 45% adhesion, but no confluent layer was found after 1 week.
Preseeding of these valves with autologous fibroblasts resulted in an endothelial
cellular adhesion of 76% and a confluent endothelial cell layer after 7 days. The
layer remained stable for at least 21 days. Results of staining for collagen IV, factor
VIII, and CD31 were positive on the luminal side of these valves, indicating the
synthesis of matrix proteins and viability of the cells. Pretreatment of commercially
available porcine valves with 10% citric acid and preseeding with autologous
fibroblasts followed by endothelial cell seeding resulted in an adhesion of 78%. The
cells formed a confluent cell layer after 7 days.
Conclusions: Pretreatment of glutaraldehyde-fixed porcine aortic valves with citric
acid established a surface more suitable for cellular attachment. Preseeding these
valves with autologous fibroblasts resulted in a confluent endothelial cell layer on
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the luminal surface. Flow tests and animal experiments are necessary for further
assessment of durability and shear stress resistance.
The degeneration of glutaraldehyde-fixedvalves, with subsequent calcification and tis-sue failure, is the main disadvantage of thesevalvular prostheses. Different strategieshave been developed to increase biocompat-ibility and durability.1-4 Covering the surface
of porcine glutaraldehyde-fixed valve prostheses with au-
tologous endothelial cells (ECs) of the recipient may delay
valve degeneration and further reduce thromboembolic
events. However, a durable EC lining has been established
with only limited success on commercially available glutar-
aldehyde-fixed aortic valves.5-12 The purpose of our study
was to develop a new treatment procedure for these valve
prostheses, enabling seeding of viable human ECs to cover
the entire luminal surface. An additional goal was to achieve
a confluent EC layer that would remain stable for at least 21
days under culture conditions.
Material and Methods
Valves and Cells
Porcine valve-containing aortic roots were dissected from healthy
Landrace pigs. The hearts were obtained from the local slaughter-
house. After preparation, the miniroots were incubated in 0.2%
glutaraldehyde, buffered with phosphate-buffered saline solution
(Dulbecco buffer without calcium and magnesium ion; Biochrom
AG, Berlin, Germany) for at least 7 days. For the first dish
experiments, aortic wall pieces with a surface of 4 cm2 were taken.
For the seeding experiments, complete valve-containing miniroots
were used.
Human ECs and fibroblasts were isolated from saphenous vein
pieces as described previously elsewhere.13-15 In brief, human
saphenous vein pieces with a mean length of 9.8  4.6 cm (range
4.1-25 cm) were stored in medium M199 Earle (1), with sodium
carbonate at 2.2 g/L without L-glutamine (M-199; Biochrom). The
vein pieces were left over from routine aortocoronary bypass
operations, and the patients had given their informed consent that
these pieces could be used in the laboratory. The local ethic
committee approved the anonymous use of the saphenous vein
pieces for this experimental study. The vein pieces were cannu-
lated, rinsed with buffered medium, and incubated with 0.1%
collagenase (Worthington Biochemical Corporation, Lakewood,
NJ) for 20 minutes at 37°C with 5% carbon dioxide. Thereafter the
collagenase reaction was stopped and the cell suspension was
centrifuged at 1000 rpm for 10 minutes. The cell pellet was
resuspended in EC growth medium (PromoCell GmbH, Heidel-
berg, Germany) and plated on culture dishes. For isolation of the
fibroblasts, the same vein pieces were again filled with 0.1%
collagenase and incubated for 30 minutes. This procedure was
repeated twice. Again, the cell suspension was centrifuged at 1000
rpm for 10 minutes, the pellet was resuspended in fibroblast
growth medium (PromoCell), and the resultant suspension was
plated on culture dishes. For passaging, both cell types were
digested with trypsin after reaching confluence and then centri-
fuged, resuspended in cell medium, and plated again. For cell
counting, 30 L of the resuspended cell suspension was incubated
with trypan blue and counted with a Neubauer chamber.
Culture Dish Experiments With Porcine Aortic Wall
Pieces
Twenty aortic wall pieces of 4 cm2 were divided into five groups
(n4 each group). Group A had no treatment after glutaraldehyde
fixation. All pieces of the following four groups were incubated
with M-199 for 24 hours at 4°C. Group B had no further treatment,
and groups C, D, and E were then incubated with citric acid at
concentrations of 5%, 10%, and 15%, respectively. This was
followed by washing with distilled water until a neutral pH was
reached. The pieces then were put into 6-well culture dishes, all of
which were incubated with 5 106 ECs. After 24 hours the pieces
were cut in half and one part was examined with the scanning
electron microscope. The second part of each piece was kept under
culture conditions for 7 days, after which these pieces were also
examined under the scanning electron microscope.
For assessment of possible toxic effects of glutaraldehyde
released from the glutaraldehyde-fixed valves, the different proce-
dures were tested in five groups (n  3 each). Group A1 had no
pretreatment but washing in 1000 mL physiologic sodium chloride
solution for 10 minutes; all other groups had incubation with
M-199 for 24 hours. Group B1 had no further treatment, and
groups C1, D1, and E1 were treated with citric acid at concentra-
tions of 5%, 10%, and 15%, respectively. All these pieces were put
into culture dishes onto a confluent EC layer. After an incubation
time of 72 hours, the dishes were examined for any changes within
the ECs.
Cell Seeding on Aortic Miniroots
According to the results of the culture dish experiments, 12 glu-
taraldehyde-fixed aortic miniroots were divided into three groups
of four valves each. Group 1 had no pretreatment but was washed
in physiologic sodium chloride solution for 10 minutes. Groups 2
and 3 were incubated with M-199 for 24 hours. Group 3 valves
underwent additional pretreatment with 10% citric acid for 5
minutes followed by washing with distilled water until a neutral
pH was reached. The miniroots were then put into the cylinder of
our seeding device (Figure 1). Two valves of each group were
seeded with only ECs, whereas the others were preseeded with
autologous fibroblasts followed by EC seeding.
For fibroblast seeding the device was filled with fibroblast
growth medium and a cell suspension containing 2.4  107 fibro-
blasts on average (range 1.2-4.1  107 cells). The seeding proce-
dure lasted for a period of 24 hours. Every 30 minutes the device
rotated for 150 seconds, stopping in a different position for the
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next resting period to ensure that all parts of the aortic roots were
exposed to cell seeding. After the seeding procedure, the valves
were kept under culture conditions for 7 days, followed by EC
seeding. EC seeding was done analogously to fibroblast seeding.
The average number of ECs was 4.3  107 (range 1.8-6  107
cells). The first specimen for scanning electron microscopic ex-
amination and immunohistochemical staining was taken directly
after the seeding procedure. One leaflet of each valve and one wall
piece of the sinus of Valsalva were taken directly after EC seeding,
the second specimen was taken 7 days after EC seeding, and the
last was taken 21 days after EC seeding.
Cell Seeding on Commercially Available Porcine
Aortic Valve Prostheses
Three commercially available stentless porcine aortic valve pros-
theses (Freestyle 21 and 23 mm; Medtronic, Inc, Minneapolis,
Minn) were put into the seeding device analogously to the valve-
containing aortic roots. The valves were incubated in M-199 for 24
hours at 4°C and pretreated with 10% citric acid for 5 minutes.
After washing with distilled water until a neutral pH was reached,
the valves were preseeded with fibroblasts, followed by EC seed-
ing as described previously. Cell numbers were 1.9  107, 2.2 
107, and 2.8  107 cells for the fibroblast seeding. Specimens of
the free aortic wall were taken directly after the seeding procedure
and 7 days later. ECs were then seeded on these valves as de-
scribed previously. The cell numbers were 1.1  108, 3.9  107,
and 2.2  107 cells. One leaflet of each valve and one wall piece
of the sinus of Valsalva were taken directly after EC seeding, the
second specimen was taken 7 days after EC seeding, and the last
was taken 21 days after EC seeding.
Immunohistochemical Staining
Specimens of the aortic wall and valve leaflets were frozen and
stored in liquid nitrogen. Eight-micrometer sections were stained
with monoclonal antibodies against factor VIII, CD31 (DAKO
Diagnostika GmbH, Hamburg Germany), and collagen IV (Sigma,
Deisnhofen, Germany). For factor VIII staining a polyclonal anti-
body against antirabbit immunoglobulin G (Immundiagnostik,
Bensheim, Germany) was used. Collagen IV and CD31 stainings
were counterstained with a polyclonal antibody against mouse
immunoglobulin G (CHEMICON International, Inc, Temecula,
Calif). The results were validated with negative control stainings
without the primary antibody. For confirmation of the immunoflu-
orescence results, additional peroxidase staining was performed.
After incubation with the primary antibodies against factor VIII,
CD31, and collagen IV, an antimouse immunoglobulin G antibody
(DAKO, Hamburg, Germany) was added and stained with 3-ami-
no-9-ethylcarbazole (AEC; DAKO). Negative control preparations
were done analogously to the fluorescence staining.
Scanning Electron Microscopy
Only cell layers with the typical cobblestone morphologic charac-
teristics were accepted as EC layers. For analysis 10 visual fields
of each specimen were evaluated under 1000 magnification. Of
the leaflets, both fibrosal and ventricularis surfaces were evaluated.
EC covering was assessed semiquantitatively by two examiners
and classified as 100%, 75%, 50%, or 25%. A mean value of 95%
or greater was thought to represent a confluent EC layer.
Results
Dish Experiments With Porcine Aortic Wall Pieces
EC seeding on glutaraldehyde-fixed aortic wall pieces re-
sulted in sporadic surviving ECs on the surface (group A,
Table 1). These cells completely disappeared 7 days after
the cell seeding. No viable cells were found on the ground
of the culture dish. Incubation with M-199 for 24 hours
before EC seeding resulted in scattered cells on the surface
of the aortic wall pieces (Figure 2). These cells also disap-
peared within 7 days. Nevertheless, on the bottoms of these
culture dishes viable ECs had grown to confluence within
this time.
Citric acid pretreatment at concentrations of 5% and 10%
improved the initial result of EC seeding. The aortic wall
pieces of both groups showed a confluent EC layer after 7
days (Figure 3). Those pieces incubated with 15% citric acid
had only scattered ECs after cell seeding. Seven days after
TABLE 1. Results of the dish experiments
Group EC survival Confluent EC layer after 7 d Cell death
A Neg Neg
B Pos Neg
C Pos Pos
D Pos Pos
E Pos Neg
A1 Strongly pos
B1 Neg
C1 Neg
D1 Neg
E1 Weakly pos
Figure 1. Cell seeding device. Valve is fixed in cylinder so that all
parts are in contact with cell suspension. During seeding proce-
dure, cylinder is rotated every 30 minutes to expose different
parts of valve to cell seeding.
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that only islands of connected ECs were seen without reach-
ing confluence.
In the toxicity testing glutaraldehyde-fixed aortic wall
pieces (group A1; Table 1) had a marginal zone without
viable cells of 2.1 0.7 cm surrounding them after 72 hours
of incubation (Figure 4, A). On the remaining culture dish,
however, a confluent EC layer was seen. Glutaraldehyde-
fixed aortic wall pieces after incubation with M-199 for 24
Figure 2. Aortic wall piece, glutaraldehyde fixed and incubated with M-199 for 24 hours, 7 days after EC seeding.
No viable cells were observed under scanning electron microscopy (original magnification 500).
Figure 3. EC seeding on glutaraldehyde-fixed aortic wall piece after pretreatment with 5% citric acid after 7 days
under culture conditions. Confluent EC layer is seen under scanning electron microscopy (original magnification
500).
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hours (group B1) were still surrounded by a confluent EC
layer after 72 hours of incubation with no evidence of
further cell death. Aortic wall pieces pretreated with M-199
incubation and 5% or 10% citric acid also did not induce
any cell death after 72 hours (Figure 4, B). Aortic wall
pieces of group E1 (15% citric acid) did not clearly induce
cell death; the confluent cell layer, however, was somewhat
dispersed.
Seeding on Valve-containing Aortic Roots
EC seeding. Isolated EC seeding on group 1 valves
resulted in isolated, rounded up ECs on the luminal surface
directly after the seeding procedure. After 7 days no ECs
were seen on the leaflets or on the free wall.
Group 2 valves seeded with ECs had small islands of
ECs scattered within the luminal surface of the valves.
Initial cell attachment was 24%. At 7, 14, and 21 days after
the seeding procedure, although ECs were seen under scan-
ning electron microscopy they did not reach confluence.
The mean covered areas of the luminal surface were 30%,
35%, and 35% after 7, 14, and 21 days, respectively. Im-
munohistochemical staining for factor VIII proved some of
these cells to be viable. On the bottoms of the culture dishes,
ECs had grown to confluence after 7 days.
Figure 4. Toxicity testing. A, Arrows indicate margin of glutaraldehyde-fixed aortic wall piece that was only
washed in physiologic sodium chloride solution for 10 minutes. Surrounding wall piece, no viable ECs are seen.
B, Aortic wall piece pretreated with 10% citric acid. Wall piece lies directly on still confluent cell layer. There is
no evidence of cell death.
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On group 3 valves ECs also formed only islands upon the
surface (Figure 5). Initial attachment was 45%, but the mean
covered areas were only 35%, 45%, and 65% after 7, 14,
and 21 days, respectively. Immunohistochemical staining
for factor VIII and CD31 also proved the cells to be viable.
A confluent or nearly confluent cell layer, however, was not
seen on any of the valves.
EC seeding after preseeding with autologous fibro-
blasts. On group 1 valves fibroblast attachment was 45%.
EC seeding resulted in an attachment of 26%. Under scan-
ning electron microscopy islands of cell layers were seen,
scattered over the whole luminal surface. Mean confluence
was 25% after 7, 14, and 21 days. Immunohistochemical
staining for factor VIII and CD31 proved the cells to be
viable.
Fibroblast seeding on group 2 valves resulted in an
attachment of 70%. EC seeding on these valves had an
initial attachment of 72%. The mean surface areas covered
by ECs were 80%, 90%, and 95% after 7, 14, and 21 days,
respectively. In one of these valves a confluent EC layer was
seen 14 days after EC seeding; this layer remained stable
after 21 days. The cells were proved viable by immunohis-
tochemical stainings and grew to confluence on the bottom
of the culture dish.
On group 3 valves fibroblast attachment was 78% (Fig-
ure 6). EC seeding resulted in an initial attachment of 76%.
Directly after seeding, the ECs formed a nearly confluent
cell layer. Both valves had confluent EC layers at 7, 14, and
21 days after the seeding procedure (Figure 7). Immunohis-
tochemical staining for factor VIII and CD31 proved the
cells to be viable. The cell layer also stained positively for
collagen IV (Figure 8, A and B).
Seeding on commercially available porcine aortic
valves. Corresponding to the previous results, these valves
had pretreatment including 24 hours of incubation in M-199
followed by incubation with 10% citric acid and washing
with distilled water until a neutral pH was reached. The
valves were also preseeded with autologous fibroblasts,
with an initial attachment of 76%. EC seeding resulted in a
nearly confluent cell layer directly after the seeding proce-
dure with an initial attachment of 78%. The cells grew to
confluence after 7 days under culture conditions. The con-
fluent cell layers remained stable for 21 days, and the cells
stained positively for factor VIII and CD31 on the free wall
as well as on the leaflets (Figure 9, A and B). The luminal
surface also stained positively for collagen IV. The conflu-
ent cell layer reached nearly to the polyester cloth covering.
On this artificial surface itself, however, no ECs were found.
Discussion
Seeding of human ECs on biologic valve prostheses has
been reported by several authors.5-12,16-20 The results, how-
ever, remained poor when glutaraldehyde-fixed valves were
subjected to cell seeding. Continuing releases of toxic glu-
taraldehyde and remaining free aldehyde groups were as-
sumed to be the major reasons.8-12 Although initial seeding
on extensively rinsed valves was successful,8 the cells did
not survive 7 days but rounded up and lost adhesion within
2 days. This agrees with the results of toxicity testing in our
studies. Glutaraldehyde-fixed aortic wall pieces caused cell
death of surrounding cultured human ECs. After incubation
with buffered cell medium for 24 hours, however, the aortic
wall pieces no longer showed cytotoxicity. Although fixa-
tion with complete cross-linking takes 7 days, unbound
glutaraldehyde can be washed out more quickly, because
when glutaraldehyde cross-links with collagen fibers it is
bound covalently. In this state it is no longer reactive and
cannot simply be washed out. Therefore only the unbound
glutaraldehyde overhang, much less than the initial amount,
must be washed out. However, the obvious loss of cytotox-
icity indicated that no glutaraldehyde was released by the
tissue.
Although the valvular leaflets are of greater clinical
interest, we used aortic wall pieces for the toxicity testing.
We did so because the free aortic wall has a smooth surface.
This facilitated the comparison of the results of EC seeding,
whereas the wavy surface of isolated leaflets proved to be
more problematic in this setting. The conclusion from these
experiments was that the release of unbound glutaraldehyde
from the valves could be avoided by extensive rinsing with
buffered solutions.
Although initial adhesion of human ECs on rinsed valves
was successful, the cells did not survive longer than 3 days.8
After implantation in a primate model, the complete cell
Figure 5. Islands of viable ECs on group C valves 7 days after
seeding procedure. Arrows indicate margin of EC layer (scanning
electron microscopy, original magnification 100).
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layer was lost under in vivo conditions.10 Glutaraldehyde
fixing cross-links collagen fibers by way of the amino
groups of the proteins. These cross-links are initiated with
the formation of a Schiff base between an amino group and
glutaraldehyde (Figure 10). This product then reacts with
another amino group to form a Schiff base. Alternatively, it
reacts21 according to aldol condensation (Figure 10). These
reactions are responsible for the reduced immunogenicity of
the prostheses and for their increased stiffness relative to
fresh porcine aortic valves. The cross-links also, however,
result in a hydrophobic surface, thus reducing the capability
of cells to adhere. The pretreatment with -amino oleic acid
used for the Medtronic Freestyle prosthesis decreases tissue
calcification22 and improves durability of the valves. The
-amino oleic acid reacts with free aldehyde groups, thus
reducing the cytotoxicity of the tissue. However, it further
reduces hydrophilia of the surface by inducing large hydro-
phobic aliphatic chains into the collagen fibers. Cells attach
to a surface by pseudopodia that use noncovalent bonds.
This primary attachment therefore requires a hydrophilic
surface. Cross-linking of the collagen fibers resulting from
glutaraldehyde-fixation reduces hydrophilia of the surface
(Figure 10). Our hypothesis was that the poor cell attach-
ment to glutaraldehyde-fixed surfaces was caused by these
cross-links rather than by the toxicity of the aldehyde. This
hypothesis was supported by the results of the toxicity
testing in this study. The adhesion of fibroblasts on these
valves was better than that of ECs, although fibroblasts did
not reach confluence either. Fibroblasts obviously had a
better ability to adhere on different surfaces than did ECs.
Additionally, their potential to build intercellular matrix
proteins further improved their adhesion.
Because fibroblasts did not form confluent cell layers, we
decided that an additional treatment of the valves was
Figure 6. Fibroblasts seeded on group C valves (scanning electron microscopy, original magnification 1000).
Figure 7. Confluent EC layer on group C valves preseeded with
autologous fibroblasts (scanning electron microscopy, original
magnification 1000).
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necessary. Pretreatment with different amino acids was re-
ported to improve cellular adhesion on glutaraldehyde-fixed
valves.3-11 Incubation with an acidic pH particularly im-
proved the success of cell seeding.9 We chose citric acid, a
strong organic acid with four carboxyl-groups that binds to
amino groups of the collagen fibers under salification (Fig-
ure 10). This strongly increases hydrophilia of the surface,
thus enhancing cellular attachment. The pretreatment mark-
edly improved cellular adhesion after cell seeding. EC seed-
ing on such pretreated valves resulted in much higher at-
tachment than seen on untreated valves. Therefore the
pretreatment clearly had changed the surface properties to
improve cellular adhesion. Seeding of ECs alone, however,
did not result in a complete confluent cell layer. Successful
EC seeding on photo-oxidized bioprostheses, acellular ma-
trix, and decellularized valves has been reported by several
groups.16-20 Photo-oxidation avoids extensive cross-linking
of collagen fibers but enhances hydrophilic properties
through the oxidation process. Explanted valves showed
tissue degeneration but no inflammatory response.21 The
success of cell seeding on these xenogenic tissue valves
supports our hypothesis that hydrophilia is an important
factor for cell seeding. Seeding on unfixed but decellular-
ized valves19 was successful, indicating the ability of ECs to
attach to cell-free surfaces.
Despite the disadvantages of the fixation procedure, we
chose glutaraldehyde-fixed valves as scaffolds for tissue
engineering. The manufacturing of these prostheses is al-
Figure 8. Immunohistochemical staining for collagen IV of group C valves after seeding with fibroblasts and ECs.
A, Specimen clearly are stained positively for collagen IV at luminal surface, as indicated by red peroxidase
reaction. B, Negative control. Small cell layer (stained blue) is seen, but no positive peroxidase reaction is found.
Figure 9. A, Immunohistochemical staining with factor VIII antibody and counterstaining with fluorescein of leaflets
of commercially available porcine heart valve 21 days after cell seeding. Cells on surface are stained positively
for factor VIII (fluorescing green), proving them to be viable ECs. B, Immunohistochemical staining with CD31-
antibody and peroxidase reaction of leaflets of commercially available porcine heart valve 21 days after cell
seeding. Cells on surface are stained positively for CD31 (stained red).
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ready standardized, the glutaraldehyde-induced cross-link-
ing reduces immunogenicity, and the fixation process facil-
itates surgical handling. If surface covering of these valves
by ECs could delay tissue degeneration, these advantages
would be of great importance for clinical use. Although ECs
attach to many surfaces, the intensity of adhesion and sub-
sequent stability of the cell layer depend mainly on the
synthesis of extracellular matrix proteins. ECs synthesize
collagen IV, an important part of the basal membranes21 of
blood vessels. However, not all matrix proteins are pro-
duced by ECs themselves. Vascular fibroblasts also partic-
ipate in the production of extracellular matrix. Fibroblast
seeding on citric acid-pretreated valves showed high attach-
ment rates. ECs seeded on these preseeded valves attached
in large numbers and formed a confluent cell layer. Because
fibroblasts obtained from different tissues differ in the types
of collagen that they build, we used vascular fibroblasts for
preseeding. This also may have contributed to the improved
endothelial adhesion of these cells. Additionally, they main-
tained their physiologic synthesis of extracellular matrix, as
was proven by the positive results of staining for collagen
IV. This collagen type is synthesized physiologically only
by ECs21 and is of great importance for the building of basal
membranes. The synthesis of extracellular matrix proteins
and components of the basal membrane is important in
cellular adhesion and potential shear stress resistance. On
the basis of the positive results of staining for these proteins,
we hypothesize that the cell layer will be resistant to phys-
iologic shear stress. However, further experimental studies
are necessary, including in vitro shear stress testing.
Before such endothelialized valves can be used in clin-
ical routine, in vivo experiments are necessary to prove
whether the EC layer improves valve durability. To exam-
ine any impact of complete endothelialization, animal ex-
periments are necessary. A potential influence on tissue
calcification could be tested by implanting such aortic wall
pieces subcutaneously in rats. Because the physical stress on
the valvular structures also plays an important role in bio-
prosthetic degeneration, a large animal in vivo model must
be used to test the complete valves under physiologic con-
ditions. An additional benefit of a complete endothelializa-
tion might be a further reduction of thromboembolic events.
However, the cell seeding procedure is costly. Therefore
only an increase in durability would justify its use in the
clinical routine. Graft selection could be done by the com-
bination of echocardiography and electron beam tomogra-
phy to chose the correct size of valve for endothelialization.
Conclusions
Pretreatment of porcine glutaraldehyde fixed aortic valves
with an organic acid improved the results of cell seeding as
a result of changes in the physicochemical properties of the
valvular tissue. Preseeding with autologous fibroblasts re-
sulted in a confluent and viable EC layer.
Figure 10. Aldol condensation is physiologic process in the cross-linking of collagen fibers.21 Glutaraldehyde forms
Schiff base with free amino groups of collagen fibers. Cross-linking can take place either as formation of another
Schiff base with amino group of second fiber or by aldol condensation. Result, however, is rather hydrophobic.
Citric acid (strong organic acid with four hydroxy groups) salifies amino groups, thereby inducing hydrophilia on
surface of collagen fiber.
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